Shanghai Haohai Biological Technology Co Ltd (Haohai Biological Technology), formerly Haohai Ltd, is a manufacturer and distributor of absorbable biomedical materials. The company provides products in the areas of orthopedics, medical aesthetics, ophthalmology and anti-adhesion. Its orthopedics product includes medical chitosan and sodium hyaluronate injection. Haohai Biological Technology offers medical aesthetic products such as rhegf, cross-linked sodium hyaluronate gel, and modified sodium hyaluronate gel for injection. The company’s ophthalmology products comprise lubricant eye drops and medical sodium hyaluronate gel. It also provides anti-adhesion products including medical sodium hyaluronate gel anti-adhesion, medical chitosan anti-adhesion and medical collagen sponge. The company develops products in various therapeutic areas such as orthopedics, medical aesthetics, ophthalmology, surgical hemostasis, post-surgery anti-adhesion and wound care. Haohai Biological Technology is headquartered in Shanghai, China.
Headquarters
China
Address
4f, No 2 Building, Alley 139, Anshun Road, Changning District, Shanghai, 200336
Website
www.3healthcare.com
Telephone
86 21 52293555
No of Employees
1,892
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
6826 (HKG)
Revenue (2021)
$271.3M
-17%
(2021 vs 2020)
EPS
XXX
Net Income (2021)
XXX
-37.9%
(2021 vs 2020)
Market Cap*
$1.8B
Net Profit Margin (2020)
XXX
-25.3%
(2021 vs 2020)
* As of and is in US$
Explore premium data & analytics
Products and Services
| Products |
|---|
| Absorbable Biomedical Materials: |
| Orthopedics |
| Medical Aesthetics |
| XXX |
| XXX |
| XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2021 | Contracts/Agreements | In February, the company agreed to acquire 38.23% Stake in Ouhua Meike (Tianjin) Medical Technology. |
| 2015 | Stock Listings/IPO | In April, the company announced its plans to raise US$305 million in a Hong Kong IPO. |
| 2007 | Incorporation/Establishment | The company was established. |
Competitor Comparison
| Key Parameters | Shanghai Haohai Biological Technology Co Ltd | Shenzhen Mindray Bio-Medical Electronics Co Ltd | Blue Sail Medical Co Ltd | Jiangsu Yuyue Medical Equipment & Supply Co Ltd | Beijing Chunlizhengda Medical Instruments Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Shanghai | Shenzhen | Zibo | Zhenjiang | Beijing |
| State/Province | Shanghai | Guangdong | Shandong | Jiangsu | Beijing |
| No. of Employees | 1,892 | 14,684 | 8,480 | 6,440 | 951 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Operating Margin
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Hou Yongtai | Chairman | Executive Board | 2010 | 59 |
| Tang Minjie | Chief Financial Officer; Director | Executive Board | 2017 | 45 |
| Tian Min | Secretary | Senior Management | 2015 | 31 |
| Wang Wenbin | Deputy General Manager | Senior Management | 2019 | 54 |
| Zhang Jundong | Deputy General Manager | Senior Management | 2019 | 47 |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer